Clinical Trials Logo

Clinical Trial Summary

This study was to investigate the Effect of Sitagliptin, a dipeptidyl peptidase-4 inhibitor, on progression of coronary atherosclerosis in patients with type 2 diabetes.


Clinical Trial Description

This study was to investigate the Effect of Sitagliptin, a dipeptidyl peptidase-4 inhibitor, on progression of coronary atherosclerosis in patients with type 2 diabetes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03602638
Study type Interventional
Source Chinese PLA General Hospital
Contact LI BO, MD
Phone +86089837330575
Email 22401919@qq.com
Status Not yet recruiting
Phase Phase 4
Start date October 1, 2018
Completion date December 1, 2020